WILMINGTON, Del. - Today, United States Attorney Benjamin L. Wallace announced the filing of civil claims against three defendants, Alpha Care Medical, LLC; its owner Nihar Gala, of Lewes, Delaware; and its laboratory director Bo Wang, of Glen Mills, Pennsylvania, in connection with an alleged scheme to defraud Medicare, Medicaid, TRICARE, and the Federal Employees Health Benefits Program through submission of false claims for laboratory diagnostic testing. The complaint filed in federal court is part of the Department of Justice's 2026 National Health Care Fraud Takedown.

In its complaint, the United States alleges that the defendants violated the False Claims Act by submitting thousands of claims to government healthcare programs for laboratory diagnostic tests that lacked a valid medical purpose to diagnose or treat patients, were conducted in violation of laboratory clinical standards that ensure reliability, and, in numerous cases, were not conducted at all.

"As alleged, the defendants exploited federal health care programs for financial gain at the expense of patients and taxpayers," said U.S. Attorney Wallace. "In the District of Delaware, we will continue to vigorously enforce the False Claims Act to protect patients, public funds, and the integrity of our health care system."

The civil claims announced by U.S. Attorney Wallace are part of a strategically coordinated, nationwide law enforcement action that resulted in charges against 455 defendants, including 90 doctors and other licensed medical professionals, for their alleged participation in health care fraud and opioid abuse schemes involving over $6.5 billion in false claims and significant patient harm, including death. The 2026 Takedown represents a new era in federal, state, and international cooperation to combat health care fraud: charges in 56 federal districts and involving 45 U.S. states and territories, the most in Department history. In addition, unprecedented international cooperation over the two-week Takedown resulted in the apprehension and return to the United States of the following health care fraudsters: one defendant in Kyrenia in connection with an over $3.7 billion scheme; two defendants in Estonia in connection with a previously charged $10.6 billion scheme; and, in the Philippines, one of FBI's Most Wanted Fraudsters in connection with a $1.2 billion telemedicine scheme. The Takedown involves the cutting-edge use of data analytics to target the worst actors; seize over $182 million in cash, houses, luxury vehicles, jewelry, and other assets; and provide full spectrum accountability for all criminal actors from doctor's offices to corporate boardrooms.

Coordinated enforcement action involving a whole-of-government approach, includes:

• Actions by the Centers for Medicare and Medicaid Services (CMS) to suspend 1,079 providers and revoke billing privileges for 1,403 providers.
• 48 Civil Monetary Payment settlements amounting to over $73 million, over 1,400 provider exclusions, and 25 actions by the U.S. Department of Health and Human Services, Office of Inspector General ("HHS-OIG") under the Civil Monetary Penalties Law seeking more than $10 billion in payments to the Medicare Trust Fund from payments that CMS caught and suspended before the funds were paid to the fraudulent providers.
• Civil charges against 13 defendants for $14.8 million in health care fraud schemes, as well as civil settlements with 31 defendants totaling $23 million.
• 928 administrative cases by the Drug Enforcement Administration (DEA) seeking the revocation of authority to handle and/or prescribe controlled substances since October 1, 2025.

The cases are being prosecuted by the Health Care Fraud Unit's National Rapid Response, Florida, Gulf Coast, Los Angeles, Midwest, New England, Northeast, Texas, and West Coast Strike Forces; U.S. Attorneys' Offices for the Middle District of Alabama, District of Arizona, Central District of California, Southern District of California, District of Colorado, District of Connecticut, District of Delaware, Middle District of Florida, Northern District of Florida, Southern District of Florida, Northern District of Georgia, District of Hawaii, District of Idaho, Northern District of Illinois, Northern District of Iowa, Southern District of Iowa, Western District of Kentucky, Eastern District of Louisiana, Middle District of Louisiana, District of Massachusetts, Eastern District of Michigan, Southern District of Mississippi, District of Montana, District of Nebraska, District of New Hampshire, District of New Jersey, District of New Mexico, Eastern District of New York, Northern District of New York, Southern District of New York, Eastern District of North Carolina, Middle District of North Carolina, Western District of North Carolina, Northern District of Ohio, Northern District of Oklahoma, Western District of Oklahoma, District of Oregon, Eastern District of Pennsylvania, Middle District of Pennsylvania, Western District of Pennsylvania, District of Puerto Rico, District of Rhode Island, District of South Carolina, District of South Dakota, Middle District of Tennessee, Western District of Tennessee, Northern District of Texas, Southern District of Texas, Western District of Texas, District of Vermont, Eastern District of Virginia, Western District of Virginia, Northern District of West Virginia, Southern District of West Virginia, Eastern District of Wisconsin, and Western District of Wisconsin; and State Attorneys General's Offices, through their MFCUs, in Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, Tennessee, Utah, Vermont, Virgin Islands, Washington, Wisconsin, and West Virginia. In addition, the MFCUs for Alabama, North Carolina, South Dakota, Texas, and Virginia participated in the investigation of federal cases announced today.

Descriptions of each case involved in today's enforcement action are available on the Department's website here.

The District of Delaware, in particular, worked with the U.S. Department of Health and Human Services Office of Inspector General (HHS-OIG) to investigate the case, which is being handled by Assistant U.S. Attorney Elizabeth Vieyra.

The government's pursuit of this matter illustrates its emphasis on combating health care fraud. One of the most powerful tools in this effort is the False Claims Act. Tips and complaints from all sources about potential fraud, waste, abuse, and mismanagement can be reported to the Department of Health and Human Services, at 800 HHS TIPS (800-447-8477).

A copy of this press release is located on the website of the U.S. Attorney's Office for the District of Delaware. A copy of the complaint is attached to this press release. Related court documents and information are located on the website of the District CourtLinks to other government and non-government sites will typically appear with the "external link" icon to indicate that you are leaving the Department of Justice website when you click the link. for the District of Delaware or on PACERLinks to other government and non-government sites will typically appear with the "external link" icon to indicate that you are leaving the Department of Justice website when you click the link. by searching for Case No. 26-cv-707.

The allegations in the complaint are merely accusations. There has been no determination of liability.